Suppression of pyramidal 5-HT1A heteroreceptors (using the CaMKIIα promoter to target pyramidal neurons) would be predicted to increase pyramidal neuron firing and display an anxiety phenotype rather than depression. The gene discussed is HTR1A; the disease is depressive symptom measurement.